Neurochemical alterations in women with borderline personality disorder and comorbid attention-deficit hyperactivity disorder

References

• Ashburner J, Friston KJ. Unified segmentation. NeuroImage 2005; 26: 839–851
   PubMed Web of Science ®Google Scholar
• Ashtari M, Kumra S, Bhaskar SL, Clarke T, Thaden E, Cervellione KL, et al. Attention-deficit/hyperactivity disorder: a preliminary diffusion tensor imaging study. Biol Psychiatry 2005; 57: 448–455
   PubMed Web of Science ®Google Scholar
• Beck AT, Steer RA. Beck-Depression-Inventory – Manual. The Psychological Corporation, San Antonio, TX 1987
   Google Scholar
• Bernstein EM, Putnam FW. Development, reliability, and validity of a dissociation scale. J Nerv Ment Dis 1986; 174: 727–735
   PubMed Web of Science ®Google Scholar
• Bohus M, Limberger MF, Frank U, Sender I, Gratwohl T, Stieglitz RD. Entwicklung der Borderline-Symptom-Liste. Psychotherapie Psychosomatik Medizinische Psychologie 2001; 51: 201–211
   PubMed Web of Science ®Google Scholar
• Bohus M, Limberger M, Frank U, Chapman A, Kühler T, Stieglitz RD. Psychometric properties of the Borderline Symptom List. Psychopathology 2007; 40: 126–132
   PubMed Web of Science ®Google Scholar
• Bozkurt A, Zilles K, Schleicher A, Kamper L, Arigita ES, Uylings HB, et al. Distributions of transmitter receptors in the macaque cingulate cortex. NeuroImage 2005; 25: 219–229
   PubMed Web of Science ®Google Scholar
• Carrey N, MacMaster FP, Fogel J, Sparkes S, Waschbusch D, Sullivan S. Metabolite changes resulting from treatment in children with ADHD: a 1H-MRS study. Clin Neuropharmacol 2003; 26: 218–221
   PubMedGoogle Scholar
• Castellanos FX, Lee PP, Sharp W, Jeffries NO, Greenstein DK, Clasen LS, et al. Developmental trajectories of brain volume abnormalities in children and adolescents with attention-deficit/hyperactivity disorder. J Am Med Assoc 2002; 288: 1740–1748
   PubMed Web of Science ®Google Scholar
• Clark JB. N-Acetylaspartate: a marker for neuronal loss or mitochondrial dysfunction. Dev Neurosci 1998; 20: 271–276
   PubMed Web of Science ®Google Scholar
• Courvoisie H, Hooper SR, Fine C, Kwock L, Castillo M. Neurometabolic functioning and neuropsychological correlates in children with ADHD-H: preliminary findings. J Neuropsychiatry Clin Neurosci 2004; 16: 63–69
   PubMed Web of Science ®Google Scholar
• Davids E, Gastpar M. Attention deficit hyperactivity disorder and borderline personality disorder. Prog Neuropsychopharmacol Biol Psychiatry 2005; 29: 865–877
   PubMed Web of Science ®Google Scholar
• Davidson RJ, Putnam KM, Larson CL. Dysfunction in the neural circuitry of emotion regulation – a possible prelude to violence. Science 2000; 289: 591–594
   PubMed Web of Science ®Google Scholar
• de Graaf RA. In vivo NMR spectroscopy: Principles and techniques. John Wiley & Sons, Chichester 1998
   Google Scholar
• Derogatis LR. SCL-90: Administration, Scoring, and Procedures Manual – I for the R(evised) version and other instruments of the psychopathology rating scale series. John Hopkins University, Baltimore, MD 1977
   Google Scholar
• Fan J, McCandliss BD, Fossella J, Flombaum JI, Posner MI. The activation of attentional networks. NeuroImage 2005; 26: 471–479
   PubMed Web of Science ®Google Scholar
• Fayed N, Modrego PJ. Comparative study of cerebral white matter in autism and attention-deficit/hyperactivity disorder by means of magnetic resonance spectroscopy. Acad Radiol 2005; 12: 566–569
   PubMed Web of Science ®Google Scholar
• First MB, Gibbon M, Spitzer RL, Williams JBW, Benjamin LS. Structured Clinical Interview for DSM-IV Axis II Personality Disorders (SCID-II). American Psychiatric Press, Washington, DC 1997
   Google Scholar
• Fossati A, Novella L, Donati D, Donini M, Maffei C. History of childhood attention deficit/hyperactivity disorder symptoms and borderline personality disorder: a controlled study. Comp Psychiatry 2002; 43: 369–377
   PubMed Web of Science ®Google Scholar
• Franke GH. Eine weitere Überprüfung der Symptom-Check-Liste (SCL-90-R) als Forschungsinstrument. Diagnostica 1992; 38: 160–167
   Google Scholar
• Friedel RO. Dopamine dysfunction in borderline personality disorder: a hypothesis. Neuropsychopharmacology 2004; 29: 1029–1039
   PubMed Web of Science ®Google Scholar
• Gallinat J, Kunz D, Lang UE, Neu P, Kassim N, Kienast T, et al. Association between cerebral glutamate and human behaviour: the sensation seeking personality trait. NeuroImage 2007; 34: 671–678
   PubMed Web of Science ®Google Scholar
• Govindaraju V, Young K, Maudsley AA. Proton NMR chemical shifts and coupling constants for brain metabolites. NMR Biomed 2000; 13: 129–153
   PubMed Web of Science ®Google Scholar
• Grosjean B, Tsai GE. NMDA neurotransmission as a critical mediator of borderline personality disorder. J Psychiatry Neurosci 2007; 32: 103–115
   PubMed Web of Science ®Google Scholar
• Halperin JM, Schulz KP. Revisiting the role of the prefrontal cortex in the pathophysiology of attention-deficit/hyperactivity disorder. Psychol Bull 2006; 132: 560–581
   PubMed Web of Science ®Google Scholar
• Hazlett EA, New AS, Newmark R, Haznedar MM, Lo JN, Speiser LJ, et al. Reduced anterior and posterior cingulate gray matter in borderline personality disorder. Biol Psychiatry 2005; 58: 614–623
   PubMed Web of Science ®Google Scholar
• Herpertz SC, Zanarini M, Schulz CS, Siever L, Lieb K, Möller HJ, et al. World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Personality Disorders. World J Biol Psychiatry 2007; 8: 212–244
   PubMed Web of Science ®Google Scholar
• Holcomb HH, Lahti AC, Medoff DR, Cullen T, Tamminga CA. Effects of noncompetitive NMDA receptor blockade on anterior cingulate cerebral blood flow in volunteers with schizophrenia. Neuropsychopharmacology 2005; 30: 2275–2282
   PubMed Web of Science ®Google Scholar
• Jang DP, Lee JM, Lee E, Park S, Kim JJ, Namkoong K, et al. Interindividual reproducibility of glutamate quantification using 1.5-T proton magnetic resonance spectroscopy. Magn Reson Med 2005; 53: 708–712
   PubMedGoogle Scholar
• Lehrl S. Mehrfachwahl-Wortschatz-Intelligenztest MWT-B5th edition. Spitta, Balingen 2005
   Google Scholar
• Lehrl S, Triebig G, Fischer B. Multiple choice vocabulary test MWT as a valid and short test to estimate premorbid intelligence. Acta Neurol Scand 1995; 91: 335–345
   PubMed Web of Science ®Google Scholar
• Lieb K, Zanarini MC, Schmahl C, Linehan MM, Bohus M. Borderline personality disorder. Lancet 2004; 364: 453–461
   PubMed Web of Science ®Google Scholar
• Lis E, Greenfield B, Henry M, Guile JM, Dougherty G. Neuroimaging and genetics of borderline personality disorder: a review. J Psychiatry Neurosci 2007; 32: 162–173
   PubMed Web of Science ®Google Scholar
• MacMaster FP, Carrey N, Sparkes S, Kusumakar V. Proton spectroscopy in medication-free pediatric attention-deficit/hyperactivity disorder. Biol Psychiatry 2003; 53: 184–187
   PubMed Web of Science ®Google Scholar
• Moore CM, Biederman J, Wozniak J, Mick E, Aleardi M, Wardrop M, et al. Differences in brain chemistry in children and adolescents with attention deficit hyperactivity disorder with and without comorbid bipolar disorder: a proton magnetic resonance spectroscopy study. Am J Psychiatry 2006; 163: 316–318
   PubMed Web of Science ®Google Scholar
• Murphy DG, Critchley HD, Schmitz N, McAlonan G, van Amelsvoort T, Robertson D, et al. Asperger syndrome: a proton magnetic resonance spectroscopy study of brain. Arch Gen Psychiatry 2002; 59: 885–891
   PubMed Web of Science ®Google Scholar
• Ni X, Chan K, Bulgin N, Sicard T, Bismil R, McMain S, et al. Association between serotonin transporter gene and borderline personality disorder. J Psychiatr Res 2006; 40: 448–453
   PubMed Web of Science ®Google Scholar
• Olbrich, HM, Valerius, G, Rüsch, N, Büchert, M, Thiel, T, Hennig, J, , et al. 2008. Frontolimbic glutamate alterations in first episode schizophrenia: Evidence from a magnetic resonance spectroscopy study. World J Biol Psychiatry
   PubMedGoogle Scholar
• Paris J. The diagnosis of borderline personality disorder: problematic but better than the alternatives. Ann Clin Psychiatry 2005; 17: 41–46
   PubMedGoogle Scholar
• Perlov E, Philipsen A, Hesslinger B, Büchert M, Ahrendts J, Feige B, et al. Reduced cingulate glutamate/glutamine-to-creatine ratios in adult patients with attention deficit/hyperactivity disorder – A magnet resonance spectroscopy study. J Psychiatr Res 2007; 41: 934–941
   PubMed Web of Science ®Google Scholar
• Pittenger C, Krystal JH, Coric V. Initial evidence of the beneficial effects of glutamate-modulating agents in the treatment of self-injurious behavior associated with borderline personality disorder. J Clin Psychiatry 2005; 66: 1492–1493
   PubMed Web of Science ®Google Scholar
• Posner MI, Rothbart MK, Vizueta N, Levy KN, Evans DE, Thomas KM, et al. Attentional mechanisms of borderline personality disorder. Proc Natl Acad Sci USA 2002; 99: 16366–16370
   PubMed Web of Science ®Google Scholar
• Prost RW, Mark L, Mewissen M, Li SJ. Detection of glutamate/glutamine resonances by 1H magnetic resonance spectroscopy at 0.5 Tesla. Magn Reson Med 1997; 37: 615–618
   PubMedGoogle Scholar
• Provencher SW. Estimation of metabolite concentrations from localized in vivo proton NMR spectra. Magn Reson Med 1993; 30: 672–679
   PubMed Web of Science ®Google Scholar
• Retz-Junginger P, Retz W, Blocher D, Weijers HG, Trott GE, Wender PH, et al. Wender Utah Rating Scale (WURS-k): Die deutsche Kurzform zur retrospektiven Erfassung des hyperkinetischen Syndroms bei Erwachsenen. Nervenarzt 2002; 73: 830–838
   PubMed Web of Science ®Google Scholar
• Ross B, Bluml S. Magnetic resonance spectroscopy of the human brain. Anat Rec 2001; 265: 54–84
   PubMedGoogle Scholar
• Rothman DL, Behar KL, Hyder F, Shulman RG. In vivo NMR studies of the glutamate neurotransmitter flux and neuroenergetics: implications for brain function. Annu Rev Physiol 2003; 65: 401–427
   PubMed Web of Science ®Google Scholar
• Rüsch N, Tebartz van Elst L, Ludaescher P, Wilke M, Huppertz HJ, Thiel T, et al. A voxel-based morphometric MRI study in female patients with borderline personality disorder. NeuroImage 2003; 20: 385–392
   PubMed Web of Science ®Google Scholar
• Rüsch N, Luders E, Lieb K, Zahn R, Ebert D, Thompson PM, et al. Corpus callosum abnormalities in women with borderline personality disorder and comorbid attention-deficit hyperactivity disorder. J Psychiatry Neurosci 2007a; 32: 417–422
   PubMedGoogle Scholar
• Rüsch N, Weber M, Il'yasov K, Lieb K, Ebert D, Hennig J, et al. Inferior frontal white matter microstructure and patterns of psychopathology in women with borderline personality disorder and comorbid attention-deficit hyperactivity disorder. NeuroImage 2007b; 35: 738–747
   PubMed Web of Science ®Google Scholar
• Scherk, H, Backens, M, Schneider-Axmann, T, Usher, J, Kemmer, C, Reith, W, , et al. 2007. Cortical neurochemistry in euthymic patients with bipolar I disorder. World J Biol Psychiatry. 1–10
   Google Scholar
• Schmahl C, Bohus M, Esposito F, Treede RD, Di Salle F, Greffrath W, et al. Neural correlates of antinociception in borderline personality disorder. Arch Gen Psychiatry 2006; 63: 659–667
   PubMed Web of Science ®Google Scholar
• Schmahl C, Bremner JD. Neuroimaging in borderline personality disorder. J Psychiatr Res 2006; 40: 419–427
   PubMed Web of Science ®Google Scholar
• Schmahmann JD. Disorders of the cerebellum: ataxia, dysmetria of thought, and the cerebellar cognitive affective syndrome. J Neuropsychiatry Clin Neurosci 2004; 16: 367–378
   PubMed Web of Science ®Google Scholar
• Schneider M, Retz W, Coogan A, Thome J, Rosler M. Anatomical and functional brain imaging in adult attention-deficit hyperactivity disorder – a neurological view. Eur Arch Psychiatry Clin Neurosci 2006; 256(Suppl 1)32–41
   Google Scholar
• Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, Weiller E, et al. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry 1998; 59(Suppl 20)22–33
   PubMed Web of Science ®Google Scholar
• Spitzer C, Freyberger HJ, Stieglitz RD, Carlson EB, Kuhn G, Magdeburg N, et al. Adaptation and psychometric properties of the German version of the Dissociative Experience Scale. J Trauma Stress 1998; 11: 799–809
   PubMed Web of Science ®Google Scholar
• Stone JM, Morrison P, Pilowsky LS. Glutamate and dopamine dysregulation in schizophrenia – a synthesis and selective review. J Psychopharmacol 2007; 21: 440–452
   PubMed Web of Science ®Google Scholar
• Tebartz van Elst L, Thiel T, Hesslinger B, Lieb K, Bohus M, Hennig J, et al. Subtle prefrontal neuropathology in a pilot magnetic resonance spectroscopy study in patients with borderline personality disorder. J Neuropsychiatry Clin Neurosci 2001; 13: 511–514
   PubMedGoogle Scholar
• Tebartz van Elst L, Hesslinger B, Thiel T, Geiger E, Haegele K, Lemieux L, et al. Frontolimbic brain abnormalities in patients with borderline personality disorder: a volumetric magnetic resonance imaging study. Biol Psychiatry 2003; 54: 163–171
   PubMed Web of Science ®Google Scholar
• Tebartz van Elst L, Ludaescher P, Thiel T, Büchert M, Hesslinger B, Bohus M, et al. Evidence of disturbed amygdalar energy metabolism in patients with borderline personality disorder. Neurosci Lett 2007; 417: 36–41
   PubMedGoogle Scholar
• Theberge J, Al Semaan Y, Williamson PC, Menon RS, Neufeld RW, Rajakumar N, et al. Glutamate and glutamine in the anterior cingulate and thalamus of medicated patients with chronic schizophrenia and healthy comparison subjects measured with 4.0-T proton MRS. Am J Psychiatry 2003; 160: 2231–2233
   PubMed Web of Science ®Google Scholar
• Todd RD, Botteron KN. Is attention-deficit/hyperactivity disorder an energy deficiency syndrome?. Biol Psychiatry 2001; 50: 151–158
   PubMed Web of Science ®Google Scholar
• Ward MF, Wender PH, Reimherr FW. The Wender Utah Rating Scale: an aid in the retrospective diagnosis of childhood attention deficit hyperactivity disorder. Am J Psychiatry 1993; 150: 885–890
   PubMed Web of Science ®Google Scholar